Musculoskeletal Disorders, Workforce Health and Productivity in the United States
Kate Summers, Kimberly Jinnett and Stephen Bevan
30 June 2015
This white paper summarizes what is known about musculoskeletal disorders (MSDs) in the United States and their relationship to employment. We reviewed the major existing clinical, epidemiological and labour market evidence on the prevalence and impact of MSDs in the U.S. working-age population.
The Work Foundation and the Center for Workforce Health and Performance found that the detrimental effect that MSDs have on the U.S. workforce should not be underestimated, in terms of both economic costs to the employer and economic and social costs to the individual. As more employees are expected to work until they are older and obesity levels continue to rise, MSDs are set to become an even larger issue. There are clinical and workplace interventions that can counter this trend and lessen the burden of MSDs on the U.S. labour market.
Back to reports